tradingkey.logo
tradingkey.logo
Search

Quanterix Corp

QTRX
Add to Watchlist
3.390USD
+0.510+17.71%
Close 06/18, 16:00ETQuotes delayed by 15 min
158.46MMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-18
Previous score
6.00
Change
0
The current earnings forecast score of Quanterix Corp is 6.00, ranking 169 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 6.50, with a high of 8.00 and a low of 5.00.

Analyst Rating

Based on 3 analysts
Hold
Current Rating
4.333
Target Price
+27.83%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Quanterix Corp
QTRX
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Quanterix Corp's expected revenue for the next quarter?

Quanterix Corp's expected revenue is 38.06M.

What is Quanterix Corp's price target?

Analysts forecast that Quanterix Corp's price target is USD 6.50, with the highest forecast at USD 8.00 and the lowest forecast at USD 5.00.

How have Quanterix CorpQTRX's recent earnings per share performed?

The market expectation was USD -0.37, while Quanterix CorpQTRX's earnings per share (EPS) for the previous quarter was USD -0.49. EPS for the next quarter is expected at USD -0.45.

What is the analyst rating for Quanterix Corp?

Based on the ratings of Quanterix Corp's stock from 3 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI